Thu.May 16, 2024

article thumbnail

In Big Pharma's growth rankings, Lilly took top spot from Novo Nordisk in Q1

Fierce Pharma

The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. | The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. With 18 of the industry’s top 25 companies achieving year-over-year revenue gains, Q1 came close to matching the final quarter of last year, when 21 of the top 25 companies showed increases.

Biopharma 299
article thumbnail

It’s Past Time to Prevent Polypharmacy in U.S. Healthcare

MedCity News

The dangers of polypharmacy and its increasingly wide reach across the American population make it imperative that we enhance the accuracy and efficiency of medication reconciliation processes. The post It’s Past Time to Prevent Polypharmacy in U.S. Healthcare appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA snubs another China-made PD-1 with rejection of Elevar, Hengrui's liver cancer combo

Fierce Pharma

China-made PD-1 inhibitors just can’t get a clean pass through the FDA. | China-made PD-1 inhibitors continue to struggle at the FDA. This week, the U.S. agency rejected Elevar Therapeutics and Jiangsu Hengrui Pharma's PD-1 combination in liver cancer.

FDA 290
article thumbnail

Innovation Doesn’t Always Have To Involve The Latest Tech, MD Anderson Exec Says

MedCity News

While adopting new technology is obviously a big part of healthcare innovation teams’ work, there are plenty of worthwhile initiatives that don’t involve advanced technologies, pointed out Dan Shoenthal, chief innovation officer at MD Anderson Cancer Center. The post Innovation Doesn’t Always Have To Involve The Latest Tech, MD Anderson Exec Says appeared first on MedCity News.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Fire breaks out at Novo production hub: None injured and construction timelines likely unaffected, company says

Fierce Pharma

A fire broke out Thursday on the roof of a building under construction at Novo Nordisk’s key manufacturing hub in Kalundborg, Denmark, where the drugmaker is currently charting a multi-year expansi | A fire broke out Thursday on the roof of a building under construction at Novo Nordisk’s key manufacturing hub in Kalundborg, Denmark, where the drugmaker is currently charting a multi-year expansion to boost capacity for its blockbuster diabetes and obesity drugs.

article thumbnail

J&J Joins Chase for Hot Immunology Target With $850M Proteologix Acquisition

MedCity News

Johnson & Johnson’s Proteologix acquisition adds a pipeline of bispecific antibodies, including an experimental treatment for asthma and atopic dermatitis. It’s the latest M&A deal involving molecules addressing TSLP, a key signaling protein involved in inflammation. The post J&J Joins Chase for Hot Immunology Target With $850M Proteologix Acquisition appeared first on MedCity News.

Biopharma 108

More Trending

article thumbnail

Virginia Medicaid Taps Aeroflow Health for Lactation Services

MedCity News

Virginia Medicaid beneficiaries now have access to Aeroflow Health’s breast pumps and lactation consultants. The post Virginia Medicaid Taps Aeroflow Health for Lactation Services appeared first on MedCity News.

article thumbnail

Former Sandoz exec sentenced to probation in price-fixing case

Fierce Pharma

After admitting to the crime four years ago, a former Sandoz executive will avoid hard time for his part in a generic drug price-fixing scheme. | Hector Kellum agreed to cooperate with federal investigators in 2020, admitting his part in a massive generics price-fixing scheme that spanned many companies.

236
236
article thumbnail

GSK pledges £45m to support global AMR prevention

European Pharmaceutical Review

GSK’s funding would be accessible for approved projects including those that employ new technology such as AI to improve interpretation and use complex scientific data” GSK is set to become the first founding partner of the Fleming Initiative. According to GSK, The Fleming Initiative’s will gather “world-class scientific, technology, policy and behavioural science expertise with clinical experience in a global network of centres to find, test, and scale solutions to [antimicrobial resistan

article thumbnail

Bristol Myers’ Breyanzi bags FDA nod to follow CAR-T rivals Gilead, Novartis into follicular lymphoma

Fierce Pharma

The FDA has broadened the use of Bristol Myers Squibb’s CAR-T therapy Breyanzi to another type of blood cancer. | The FDA has broadened the use of Bristol Myers Squibb’s CAR-T therapy Breyanzi to another type of blood cancer, where the CD19 CAR-T will again compete with Gilead Sciences and Novartis drugs.

FDA 176
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

TIGIT developer iTeos raises $120m, and other financings

pharmaphorum

Notable biotech financings in the last week include a $120m direct offering for iTeos, and private rounds for Lycia, Attovia, Ajax, and CinDome

108
108
article thumbnail

Employers Will Share Value-Based Care Strategies at MedCity INVEST

MedCity News

At the MedCity INVEST conference from May 21-22 at the Ritz Carlton in Chicago, a panel discussion sponsored by Quantum Health will share how employers are addressing value-based care. The post Employers Will Share Value-Based Care Strategies at MedCity INVEST appeared first on MedCity News.

95
article thumbnail

Tracking the opioid lawsuit settlements amidst calls for oversight

Pharmaceutical Technology

The US National Opioid Settlement is distributing more than $54 billion to communities grappling with the opioid crisis.

article thumbnail

Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients

PharmaTimes

The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK

Patients 106
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

DN-1508052 by Shanghai De Novo Pharmatech for Melanoma: Likelihood of Approval

Pharmaceutical Technology

DN-1508052 is under clinical development by Shanghai De Novo Pharmatech and currently in Phase I for Melanoma.

97
article thumbnail

Closed Loop and Pharmanovia investigate precision medicine combination in hypertension

PharmaTimes

The OptiZest study aims to investigate a personalised dose of Zestril in these patients

Medicine 108
article thumbnail

INZ-701 by Inozyme Pharma for Pseudoxanthoma Elasticum (PXE or Gronblad Strandberg Syndrome): Likelihood of Approval

Pharmaceutical Technology

INZ-701 is under clinical development by Inozyme Pharma and currently in Phase II for Pseudoxanthoma Elasticum (PXE or Gronblad Strandberg Syndrome).

Pharma 75
article thumbnail

CCC Named a Stevie® Award Winner for Customer Service Department of the Year in the 2024 American Business Awards®  

Copyright Clearance Center

May 16, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, was named a Bronze Stevie® Award winner for Customer Service Department of the Year in the 22nd annual American Business Awards ®. The American Business Awards are the premier business awards program in the U.S. Nicknamed the “Stevies” for the Greek word meaning “crowned,” the competition receives over 12,000 entries each year from organizations in 70 countries.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

KRAS inhibitors: The next frontier beckons

Pharmaceutical Technology

There has been several developments in the KRAS inhibitor space, shaping the KRAS inhibitors of the future.

81
article thumbnail

Roche trumpets potential ‘best-in-class’ obesity drug

pharmaphorum

Roche reports promising data with obesity candidate CT-388, bought as part of its $3.

91
article thumbnail

Pharma Pulse 5/16/24: Senators Propose $32 Billion in Annual AI Spending but Defer Regulation, Talkspace Expands Tele-Mental Health to Medicare & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

Leveraging predictive analytics to uncover new revenue streams in healthcare

Clarify Health

Chief Strategy Officers (CSOs) for health systems face the constant challenge of finding new revenue streams to cover the increasing costs of high- quality healthcare. To help tackle the problem, they are turning to predictive analytics for deep insights that can drive strategic decisions and open new revenue channels. By leveraging predictive analytics, CSOs can identify under-served areas, develop new service lines, enhance telemedicine offerings, and foster partnerships and collaborative ve

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

How a Simple Conversation Changed My Approach to Pharmaceutical Sales

Contrarian Sales Techniques

I still remember the day vividly – it was a rainy Tuesday afternoon, and I was scheduled for a pharmaceutical sales call that I had been dreading for weeks. My client was known for being tough, and I had rehearsed my pitch countless times. Little did I know, this particular call would turn out to be a turning point in my career, teaching me invaluable lessons about the art of conversation and the true essence of building relationships in the pharmaceutical industry.

article thumbnail

US Pharma and Biotech Summit 2024: Artificial Intelligence and Machine Learning Through the Eyes of the FDA

PharmExec

In an interview with Pharm Exec Associate Editor Don Tracy at Financial Times’ US Pharma and Biotech Summit, Tala Fakhouri, Associate Director for Policy Analysis, FDA, discusses the use of artificial intelligence and machine learning in drug development.

Pharma 52
article thumbnail

How to Optimize for Voice Search in Healthcare Marketing

LEVO Health

Voice search is changing the way consumers find information, and it’s quickly becoming a staple in the daily lives of patients. In healthcare marketing, staying ahead means embracing this technology to ensure patients can easily find your services. With a significant portion of the U.S. population now using voice-activated devices to ask health-related questions or locate nearby medical facilities, optimizing for voice search is not just beneficial — it’s essential.

article thumbnail

The Legal Environment for IVF and Other Assistive Reproductive Technology After Alabama’s Supreme Court and Legislative Decisions

PharmExec

Unlike for individuals or entities providing or receiving services related to in vitro fertilization (IVF), the Alabama IVF Act does not grant immunity to manufacturers, but it limits damages for their violations to the cost of an IVF cycle.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Embracing Vision, Mindset & Grit: Why I Call Florida Home

Scott Burrows

Introduction: Welcome to my blog! As a keynote motivational speaker, I’m constantly inspired by the power of vision, mindset, and grit to transform lives. Today, I want to share a little more about myself, particularly where I call home: sunny Florida. Living in Florida: Living in the Sunshine State isn’t just about the beautiful weather (although that’s definitely a bonus!).

article thumbnail

Investors put $400M into biotech licensing obesity drugs from China

PharmaVoice

The biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by Jiangsu Hengrui Pharmaceuticals, two of which are in clinical testing.

article thumbnail

NABIP Responds to CMS Statement Regarding Unauthorized Plan Switching on ACA Marketplace

PharmExec

The NABIP expressed frustration at CMS’ statement for placing blame on brokers and agents and not acknowledging evidence that switches were made by automated programs.

52
article thumbnail

ABP-671 by Jiangsu Atom Bioscience and Pharmaceutical for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval

Pharmaceutical Technology

ABP-671 is under clinical development by Jiangsu Atom Bioscience and Pharmaceutical and currently in Phase I for Chronic Kidney Disease (Chronic Renal Failure).

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A